*/
In an era where the surge of artificial intelligence (AI) captures global attention, an equally important but less discussed advancement is making waves – the intersection of neurotechnology and law. This pivotal juncture in human innovation has prompted the establishment of the Institute of Neurotechnology & Law, spearheaded by Harry Lambert, a barrister with a unique blend of expertise in product liability, privacy, and medical law.
In recent years neurotechnology has made great strides, and we now live in a world where brain to brain communication, memory scanning and transcription of thoughts to text (to name but a few) are all possible. As neurotechnology swiftly evolves, its integration into everyday life will have profound implications on privacy, ethics and personal autonomy. Suddenly we need to protect a whole new raft of rights that we never imagined needed protection; what the ethicist Rafael Yuste has called ‘neurorights’.
The foundation of the Institute comes at a critical time. It is no exaggeration to say that recent advances in neurotechnology mark a crucial moment; it is imperative that we engage in balanced and informed debates about neurorights.
The Institute of Neurotechnology & Law aims to ensure that as these technologies develop, they do so in a manner that aligns with the best interests of humanity. The core mission is to foster discussions that will guide the responsible development of neurotechnological innovations. By bringing together legal experts, technologists, bioethicists and policymakers, the Institute seeks to build a robust framework for ethical governance and legislation in this dynamic arena.
It’s common to hear debates surrounding AI, but the fascinating topic of neurotechnology and its legal implications remains largely in the shadows. The Institute of Neurotechnology and Law is set to change that, ensuring that this area receives the attention and scrutiny it deserves. Find out more at www.neurotechlaw.com
In an era where the surge of artificial intelligence (AI) captures global attention, an equally important but less discussed advancement is making waves – the intersection of neurotechnology and law. This pivotal juncture in human innovation has prompted the establishment of the Institute of Neurotechnology & Law, spearheaded by Harry Lambert, a barrister with a unique blend of expertise in product liability, privacy, and medical law.
In recent years neurotechnology has made great strides, and we now live in a world where brain to brain communication, memory scanning and transcription of thoughts to text (to name but a few) are all possible. As neurotechnology swiftly evolves, its integration into everyday life will have profound implications on privacy, ethics and personal autonomy. Suddenly we need to protect a whole new raft of rights that we never imagined needed protection; what the ethicist Rafael Yuste has called ‘neurorights’.
The foundation of the Institute comes at a critical time. It is no exaggeration to say that recent advances in neurotechnology mark a crucial moment; it is imperative that we engage in balanced and informed debates about neurorights.
The Institute of Neurotechnology & Law aims to ensure that as these technologies develop, they do so in a manner that aligns with the best interests of humanity. The core mission is to foster discussions that will guide the responsible development of neurotechnological innovations. By bringing together legal experts, technologists, bioethicists and policymakers, the Institute seeks to build a robust framework for ethical governance and legislation in this dynamic arena.
It’s common to hear debates surrounding AI, but the fascinating topic of neurotechnology and its legal implications remains largely in the shadows. The Institute of Neurotechnology and Law is set to change that, ensuring that this area receives the attention and scrutiny it deserves. Find out more at www.neurotechlaw.com
Kirsty Brimelow KC, Chair of the Bar, sets our course for 2026
What meaningful steps can you take in 2026 to advance your legal career? asks Thomas Cowan of St Pauls Chambers
Marie Law, Director of Toxicology at AlphaBiolabs, explains why drugs may appear in test results, despite the donor denying use of them
Asks Louise Crush of Westgate Wealth Management
AlphaBiolabs has donated £500 to The Christie Charity through its Giving Back initiative, helping to support cancer care, treatment and research across Greater Manchester, Cheshire and further afield
Q and A with criminal barrister Nick Murphy, who moved to New Park Court Chambers on the North Eastern Circuit in search of a better work-life balance
The appointments of 96 new King’s Counsel (also known as silk) are announced today
With pupillage application season under way, Laura Wright reflects on her route to ‘tech barrister’ and offers advice for those aiming at a career at the Bar
Jury-less trial proposals threaten fairness, legitimacy and democracy without ending the backlog, writes Professor Cheryl Thomas KC (Hon), the UK’s leading expert on juries, judges and courts
Are you ready for the new way to do tax returns? David Southern KC explains the biggest change since HMRC launched self-assessment more than 30 years ago... and its impact on the Bar
Marking one year since a Bar disciplinary tribunal dismissed all charges against her, Dr Charlotte Proudman discusses the experience, her formative years and next steps. Interview by Anthony Inglese CB
